Acadia Pharmaceutica (ACAD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ACAD | AMGN | GILD | VRTX | BIIB |
| Company | Acadia Pharmaceutica | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic | Biogen Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 16.70 | 337.03 | 84.39 | 477.70 | 200.57 |
| High | 16.81 | 338.50 | 84.65 | 479.01 | 203.56 |
| Low | 16.39 | 334.61 | 83.57 | 476.27 | 200.11 |
| Last | 16.52 | 338.26 | 83.95 | 479.35 | 203.86 |
| Change | +0.19 | +5.34 | +0.06 | +5.19 | +6.27 |
| % Change | +1.16% | +1.60% | +0.07% | +1.09% | +3.17% |
| Volume | 78,736 | 250,616 | 1,128,096 | 103,907 | 190,578 |
| 20-Day Average Volume | 1,120,138 | 1,688,932 | 6,292,804 | 942,921 | 776,597 |
| Previous Close | 16.33 | 332.92 | 83.89 | 474.16 | 197.59 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 16.11 | 329.68 | 80.08 | 479.90 | 201.59 |
| 20-Day Raw Stochastic | 68.14% | 94.35% | 92.24% | 45.25% | 61.75% |
| 20-Day Relative Strength | 51.58% | 59.06% | 72.35% | 49.72% | 44.91% |
| Weighted Alpha | -35.88 | +28.10 | +18.72 | +33.81 | -21.75 |
| Today's Opinion | 56% Sell | 96% Buy | 88% Buy | 40% Buy | 100% Sell |
| Previous Opinion | 56% Sell | 88% Buy | 88% Buy | 40% Buy | 100% Sell |
| Last Month's Opinion | 56% Sell | 88% Buy | 56% Buy | 88% Buy | 88% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +3.51% since 09/12/24 | +2.37% since 09/12/24 | +1.19% since 09/12/24 | -0.01% since 09/12/24 | +1.68% since 09/12/24 |
| Low | 15.87 on 09/13/24 | 327.15 on 09/13/24 | 81.57 on 09/13/24 | 473.75 on 09/18/24 | 192.25 on 09/13/24 |
| High | 16.81 on 09/19/24 | 339.00 on 09/18/24 | 84.61 on 09/19/24 | 490.15 on 09/16/24 | 202.79 on 09/17/24 |
| 1-Month | |||||
| %Chg | +4.76% since 08/19/24 | +3.02% since 08/19/24 | +13.03% since 08/19/24 | -1.94% since 08/19/24 | -2.35% since 08/19/24 |
| Low | 15.40 on 09/11/24 | 319.00 on 09/06/24 | 74.34 on 08/20/24 | 460.69 on 09/11/24 | 192.25 on 09/13/24 |
| High | 17.03 on 09/03/24 | 339.00 on 09/18/24 | 84.89 on 09/12/24 | 500.25 on 08/30/24 | 207.59 on 08/21/24 |
| 3-Month | |||||
| %Chg | +11.03% since 06/18/24 | +10.42% since 06/18/24 | +33.25% since 06/18/24 | +2.42% since 06/18/24 | -10.03% since 06/18/24 |
| Low | 14.73 on 06/20/24 | 303.55 on 06/20/24 | 64.86 on 06/20/24 | 458.04 on 08/13/24 | 192.25 on 09/13/24 |
| High | 19.44 on 07/31/24 | 346.85 on 07/25/24 | 84.89 on 09/12/24 | 510.64 on 08/01/24 | 238.00 on 07/12/24 |
| 6-Month | |||||
| %Chg | -11.71% since 03/19/24 | +24.34% since 03/19/24 | +14.63% since 03/19/24 | +15.27% since 03/19/24 | -7.97% since 03/19/24 |
| Low | 14.55 on 06/10/24 | 260.68 on 04/19/24 | 62.07 on 05/31/24 | 391.01 on 04/18/24 | 189.44 on 04/19/24 |
| High | 19.44 on 07/31/24 | 346.85 on 07/25/24 | 84.89 on 09/12/24 | 510.64 on 08/01/24 | 238.00 on 07/12/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 2,698,059 | 178,589,936 | 104,514,608 | 122,358,416 | 28,768,510 |
| Shares Outstanding, K | 165,221 | 536,435 | 1,245,853 | 258,053 | 145,597 |
| Annual Sales | 726,440,000 | 28,190,000,000 | 27,116,000,000 | 9,869,200,000 | 9,835,600,000 |
| Annual Net Income | -61,290,000 | 6,717,000,000 | 5,665,000,000 | 3,619,600,000 | 1,161,100,000 |
| Last Quarter Sales | 241,960,000 | 8,388,000,000 | 6,954,000,000 | 2,645,600,000 | 2,464,900,000 |
| Last Quarter Net Income | 33,390,000 | 746,000,000 | 1,614,000,000 | -3,593,600,000 | 583,600,000 |
| 60-Month Beta | 0.40 | 0.61 | 0.18 | 0.40 | -0.06 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.20 on 08/06/24 | 4.97 on 08/06/24 | 2.01 on 08/08/24 | -12.83 on 08/01/24 | 5.28 on 08/01/24 |
| Latest Earnings Date | 11/07/24 | 10/29/24 | 11/05/24 | 11/04/24 | 08/01/24 |
| Most Recent Dividend | N/A | 2.250 on 08/16/24 | 0.770 on 09/13/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 08/16/24 | 09/13/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 90.33 | 17.89 | 17.67 | 0.00 | 12.19 |